Stock News

Company Update (NYSE:DUK): Duke Energy Corp Unveils $1.1-Billion Plan to End Coal Era in Asheville, N.C.

Duke Energy Corp (NYSE:DUK) announced plans to retire its Asheville, N.C.

Company Update (NASDAQ:PBPB): Carl Warschausky Appointed to Potbelly Corp Board of Directors

Potbelly Corp (NASDAQ:PBPB) announced that Carl Warschausky has been appointed to Potbelly’s Board of Directors. Since September 2008, Mr.

Tuesday Pre-Market Insights: MannKind Corporation (MNKD), Achillion Pharmaceuticals, Inc. (ACHN), Etsy Inc (ETSY), Opko Health Inc. (OPK)

MannKind Corporation (NASDAQ:MNKD) shares increased approximately 4.5% in pre-market trading to $4.

Stock Update (NASDAQ:PSDV): pSivida Corp. Reports Positive IOP Safety Data in Phase III Trial of Medidur™ for Posterior Uveitis

pSivida Corp. (NASDAQ:PSDV), a leader in the development of sustained release drug delivery products for treating eye diseases, announced positive safety data from …

Company Update (NASDAQ:GWPH): GW Pharmaceuticals PLC- ADR Appoints Senior Industry Executive to President of North American Division and Relocates CEO to the U.S.

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) ), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced …

Company Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Announces Phase 1 Study in Pediatric Patients with Brain Tumors

Oncolytics Biotech, Inc. (USA)  (NASDAQ:ONCY) announced that following submission to the U.

Stock Update (NASDAQ:BLUE): bluebird bio Inc Announces Global Regulatory Strategy for LentiGlobin BB305 in Beta-Thalassemia Major

bluebird bio Inc (NASDAQ:BLUE) , a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based …

Stock Update (NASDAQ:ICPT): Intercept Pharmaceuticals Inc Announces Pivotal Phase 3 Clinical Trial of Obeticholic Acid in NASH

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced its plans for an international Phase 3 trial of obeticholic acid (OCA), the company’s lead FXR agonist, in patients …

Stock Update (NYSE:RIG): Transocean LTD Provides Fleet Update Summary

Transocean LTD (NYSE:RIG) issued a monthly Fleet Update Summary, which includes new contracts, changes to existing contracts, and changes in estimated planned out-of-service time …

Company Update (NYSE:RIG): Transocean LTD Announces Schedule For First Dividend Installment And Currency Election Period

Transocean LTD (NYSE:RIG) announced the schedule for the payment of the first installment of its U.S.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts